Search Count: 45
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 25
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2025-01-15 Classification: HYDROLASE/INHIBITOR Ligands: WD6, NA, CA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: WD6, NA, CA
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 47
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2025-01-15 Classification: HYDROLASE/INHIBITOR Ligands: WDF, NA, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: WDF, NA, CL
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 16
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WBE, EDO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WBE, EDO
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 15
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WBK |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WBK
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 14
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WBO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WBO
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With C145 Sulfinic Acid In Complex With Inhibitor 17
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WCZ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WCZ
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 29
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WDQ, CL, EDO, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WDQ, CL, EDO, NA
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 30
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WE8, CL, EDO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WE8, CL, EDO
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 32
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WEK |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WEK
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 27
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WEO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WEO
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 31
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WEX, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WEX, CL
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 28
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2025-01-01 Classification: HYDROLASE/INHIBITOR Ligands: WF2 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: WF2
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor Del_7
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2024-12-25 Classification: HYDROLASE/INHIBITOR Ligands: WB0, CL, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-12-25
Ligands: WB0, CL, NA
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor Del_2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-12-25 Classification: HYDROLASE/INHIBITOR Ligands: WB5 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-12-25
Ligands: WB5
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 1
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2024-12-25 Classification: HYDROLASE/INHIBITOR Ligands: WC0, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-12-25
Ligands: WC0, NA
![]() |
Crystal Structure Of Sars-Cov-2 3Cl Protease With Inhibitor 2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2024-12-25 Classification: HYDROLASE/INHIBITOR Ligands: WDK |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-12-25
Ligands: WDK
![]() |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) E166V Mutant In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 7YY, GOL
![]() |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F And E166V) In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY, VIB, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 7YY, VIB, GOL
![]() |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (T21I And E166V) In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 7YY
![]() |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) F140L Mutant In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI
